Inventor · disambiguated record
Dan Samuel Kaufman
Also filed as: KAUFMAN DAN · KAUFMAN DAN S · KAUFMAN DAN SAMUEL
9 granted patents·12 pending applications·397 citations·filing 1999–2025
89Inventor score
Files withUNIV CALIFORNIA8UNIV MINNESOTA8WISCONSIN ALUMNI RES FOUND2KAUFMAN DAN S1WISCONSIN ALUMNI REASEARCH FOU1
Top patents by PatentIndex Score
21 records- 0195US6613568B2Hematopoietic differentiation of human embryonic stem cellsWISCONSIN ALUMNI RES FOUND·Filed 2001·Granted Sep 2, 2003·49 cites·1 claims
- 0295US6280718B1Hematopoietic differentiation of human pluripotent embryonic stem cellsWISCONSIN ALUMNI REASEARCH FOU·Filed 1999·Granted Aug 28, 2001·287 cites·10 claims
- 0391US10464989B2Polypeptides, cells, and methods involving engineered CD16UNIV MINNESOTA·Filed 2015·Granted Nov 5, 2019·22 cites·16 claims
- 0485US9260696B2Method for developing natural killer cells from stem cellsKAUFMAN DAN S·Filed 2013·Granted Feb 16, 2016·23 cites·17 claims
- 0583US10640570B2Chimeric antigen receptors, compositions, and methodsUNIV MINNESOTA·Filed 2016·Granted May 5, 2020·3 cites·7 claims
- 0682US7176023B2Endothelial cells derived from primate embryonic stem cellsWISCONSIN ALUMNI RES FOUND·Filed 2002·Granted Feb 13, 2007·13 cites·4 claims
- 0780US2024417441A1Polypeptides, cells, and methods involving engineered cd16UNIV MINNESOTA·Filed 2024·Application pending·0 cites
- 0876US2024294664A1Chimeric antigen receptors, compositions, and methodsUNIV MINNESOTA·Filed 2024·Application pending·0 cites
- 0972US12098182B2Polypeptides, cells, and methods involving engineered CD16UNIV MINNESOTA·Filed 2019·Granted Sep 24, 2024·0 cites·18 claims
- 1070US11370825B2Polypeptides, cells, and methods involving engineered CD16UNIV MINNESOTA·Filed 2021·Granted Jun 28, 2022·0 cites·20 claims
- 1164US12030953B2Chimeric antigen receptors, compositions, and methodsUNIV MINNESOTA·Filed 2020·Granted Jul 9, 2024·0 cites·11 claims
- 1262US2025000974A1Combination of human natural killer cells and macrophages for cancer therapyUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1361US2004043484A1Hematopoietic differentiation of human embryonic stem cellsFiled 2003·Application pending·0 cites
- 1458US2024010980A1Natural killer cells with enhanced activityUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1552US2021145883A1Modification of Immune Cells to Increase ActivityUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1651US2024316197A1Human ipsc-derived macrophageUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1749US2022152110A1Switchable Chimeric Antigen Receptor-Engineered Human Natural Killer CellsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1849US2024277761A1Human ipsc-derived macrophages for liver repair and regenerationUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1948US2022154183A1CHMP2A as a Regulator of Natural Killer Cell-Mediated ActivityUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2048US2025255933A1Modification of Immune Cells to Increase ActivityUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 2141US2017121683A1Aryl hydrocarbon receptor disruption and enhancementUNIV MINNESOTA·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →